Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-15,900
Closed -$8.62M 5260
2024
Q3
$8.62M Sell
15,900
-11,100
-41% -$5.61M ﹤0.01% 1588
2024
Q2
$11.6M Buy
+27,000
New +$10.3M ﹤0.01% 1137
2024
Q1
Sell
-5,200
Closed -$1.98M 5065
2023
Q4
$1.98M Buy
+5,200
New +$2.42M ﹤0.01% 2924
2021
Q1
Sell
-11,300
Closed -$3.32M 4678
2020
Q4
$3.32M Buy
+11,300
New +$3.11M ﹤0.01% 1828
2018
Q4
Sell
-23,100
Closed -$1.75M 6911
2018
Q3
$1.75M Buy
+23,100
New +$2.05M ﹤0.01% 3036

Other funds holding ARGX

Barclays's ARGX Position: Q1 2026 in Review

Barclays reduced its argenx (ARGX) stake by 48% in Q1 2026, selling an estimated $3.93M and leaving 5,500 shares worth $4.02M. The position accounts for ﹤0.01% of the portfolio, ranked #1950.

Barclays first reported a position in ARGX in Q1 2018 and has held it in 30 quarters since. The position peaked at $19.1M in Q3 2023. 476 funds tracked by Wall St. Rank hold ARGX as of Q1 2026.

  • Barclays held 5,500 shares of argenx worth $4.02M as of Q1 2026.
  • Barclays sold 5,025 argenx shares in Q1 2026, an estimated $3.93M.
  • argenx made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #1950 holding.
  • Barclays first reported a position in argenx in Q1 2018 and has held it in 30 quarters since.
  • Barclays's argenx position peaked at $19.1M in Q3 2023.
  • 476 funds tracked by Wall St. Rank held argenx as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.